Health Condition 1: N958- Other specified menopausal and perimenopausal disorders
Conditions
Interventions
Intervention1: Barg-e-Gaozaban (Borago officinalis L. leaves): The drug will be pounded, sieved and mixed well to make a homogenous powder. Five gram daily will be administered orally for 12 weeks.
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: All postmenopausal women (at least 1 year without menstrual cycle) with postmenopausal symptoms as per MKI scale. All postmenopausal women with follicle stimulating hormone (FSH) more than 30 IU/ml.
Exclusion criteria
Exclusion criteria: Women with undiagnosed vaginal bleeding, surgical menopause (bilateral oophorectomy and malignancies. Use of hormone therapy or oral contraceptives within two months. Women with co-morbidities such as uncontrolled hypertension (Stage 2 hypertension more than 140/90 mmHg), uncontrolled diabetes mellitus (FBS more than 130mg/dl or PPBS more than 180mg/dl or RBS more than 200mg/dl or HbA1c more than 7.00%), uncontrolled hypothyroid Women with diagnosed psychiatric diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Kupperman Index questionnaireTimepoint: Every month for 3 months during treatment and 1 month after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| DASS-21, Vaginal Health Index score and Vaginal maturation Index Timepoint: Before intervention and after treatment at 3rd month | — |
Countries
India
Contacts
Public ContactPROF DR ARSHIYA SULTANA
National Institute of Unani Medicine
Outcome results
None listed